Patents Assigned to ProEthic Pharmaceuticals, Inc.
  • Patent number: 7390511
    Abstract: Mineral additives for preparing tablet compositions that comprise Vitamin E and optionally saw palmetto. The compositions are preferably formulated with a zinc compound and a selenium compound.
    Type: Grant
    Filed: February 22, 2007
    Date of Patent: June 24, 2008
    Assignee: ProEthic Pharmaceuticals, Inc.
    Inventors: Bryce M. Harvey, V. Stan Mader
  • Publication number: 20070172528
    Abstract: Mineral additives for preparing tablet compositions that comprise Vitamin E and optionally saw palmetto. The compositions are preferably formulated with a zinc compound and a selenium compound.
    Type: Application
    Filed: February 22, 2007
    Publication date: July 26, 2007
    Applicant: ProEthic Pharmaceuticals, Inc.
    Inventors: Bryce Harvey, V. Mader
  • Patent number: 7186421
    Abstract: Mineral additives for preparing tablet compositions that comprise Vitamin E and optionally saw palmetto. The compositions are preferably formulated with a zinc compound and a selenium compound.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: March 6, 2007
    Assignee: ProEthic Pharmaceuticals, Inc.
    Inventors: Bryce M. Harvey, V. Stan Mader
  • Patent number: 7022350
    Abstract: A dietary supplement for treating or preventing prostate disease and/or vascular disease including saw palmetto, d-alpha tocopherol, d-gamma tocopherol, d-delta tocopherol, d-beta tocopherol, selenium, lycopene, zinc, folic acid, vitamin B12, and vitamin B6, each in a therapeutically effective amount.
    Type: Grant
    Filed: April 27, 2004
    Date of Patent: April 4, 2006
    Assignee: Proethic Pharmaceuticals, Inc.
    Inventors: Bryce M. Harvey, Philip M. Knight
  • Patent number: 6974595
    Abstract: New pharmaceutical compositions for oral use containing Diclofenac together with alkali metal bicarbonates in amounts of from 20 to 80 by weight with respect to Diclofenac are described. These compositions are entirely palatable and free from any unpleasant taste or other side effects; in particular, these formulations permit to obtain in human patients higher Cmax of the active principle and shorter Tmax together with a lower coefficient of variation.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: December 13, 2005
    Assignee: ProEthic Pharmaceuticals, Inc.
    Inventors: Alberto Reiner, Giorgio Reiner